Title:
CDK2 INHIBITOR AND PREPARATION METHOD THEREFOR
Document Type and Number:
WIPO Patent Application WO/2022/135442
Kind Code:
A1
Abstract:
The present invention provides a CDK2 inhibitor and a preparation method therefor. Specifically, the present invention provides a compound as represented by formula I or a pharmaceutically acceptable salt and tautomer thereof. Groups are as defined in the present invention. The compound as represented by formula I may be used as a cyclin-dependent kinase inhibitor, and is used for preventing and/or treating a protein-dependent kinase or cyclin related disease, such as a cell proliferation disease, cancer, or immune disease.
Inventors:
ZOU HAO (CN)
LIU HAOMIAO (CN)
LI YUNFEI (CN)
GONG HONGLONG (CN)
ZHANG CHAO (CN)
PANG XIAMING (CN)
ZHANG FANG (CN)
LIU HAOMIAO (CN)
LI YUNFEI (CN)
GONG HONGLONG (CN)
ZHANG CHAO (CN)
PANG XIAMING (CN)
ZHANG FANG (CN)
Application Number:
PCT/CN2021/140312
Publication Date:
June 30, 2022
Filing Date:
December 22, 2021
Export Citation:
Assignee:
TUOJIE BIOTECH SHANGHAI CO LTD (CN)
International Classes:
C07D231/40; A61K31/415; A61P35/00; C07D401/12; C07D403/12; C07D413/12
Domestic Patent References:
WO2020157652A2 | 2020-08-06 | |||
WO2005051919A1 | 2005-06-09 |
Foreign References:
CN1518543A | 2004-08-04 | |||
CN1379668A | 2002-11-13 | |||
CN1373662A | 2002-10-09 | |||
CN1290164A | 2001-04-04 |
Attorney, Agent or Firm:
GE CHENG & CO., LTD (CN)
Download PDF: